{"id":2286,"date":"2023-06-25T17:55:36","date_gmt":"2023-06-25T17:55:36","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/xipamide\/"},"modified":"2023-06-25T18:01:12","modified_gmt":"2023-06-25T18:01:12","slug":"xipamide","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/xipamide\/","title":{"rendered":"Xipamide"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/kidneydiseaseclinic.net\/renaldrugs\/img\/Xipamide.JPG\"><\/p>\n<h3>  CLINICAL USE<\/h3>\n<p>Thiazide diuretic: Hypertension   Oedema<\/p>\n<h3> DOSE IN NORMAL RENAL FUNCTION<\/h3>\n<p>Oedema: 40\u201380 mg in the morning Maintenance: 20 mg in the morning Hypertension: 20 mg in the morning<\/p>\n<h3>  PHARMACOKINETICS<\/h3>\n<li> Molecular weight &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; : 354.8<\/li>\n<li>  %Protein binding  &nbsp; &nbsp; &nbsp;  &nbsp;  &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; : 99<\/li>\n<li>  %Excreted unchanged in urine &nbsp; &nbsp; : 50<\/li>\n<li> Volume of distribution (L\/kg) &nbsp; &nbsp; &nbsp; : 10\u201321 litres<\/li>\n<li>half-life \u2013 normal\/ESRD (hrs)&nbsp; &nbsp; &nbsp; : 5\u20138\/9\u201332<br \/>\n<h3>  DOSE IN RENAL IMPAIRMENT<\/h3>\n<h4>GFR (mL\/MIN)<\/h4>\n<\/li>\n<li> 20 to 50  &nbsp; &nbsp; : Dose as in normal renal function<\/li>\n<li> 10 to 20  &nbsp; &nbsp; : Dose as in normal renal function<\/li>\n<li> &lt;10 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; : Dose as in normal renal function<br \/>\n<h3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES<\/h3>\n<\/li>\n<li> CAPD  &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;: Unknown dialysability. Dose as in normal renal function<\/li>\n<li> HD &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; : Dialysed. Dose as in normal renal function<\/li>\n<li>HDF\/high flux  &nbsp; : Dialysed. Dose as in normal renal function<\/li>\n<li>CAV\/VVHD  &nbsp; &nbsp; &nbsp;: Unknown dialysability. Dose as in normal renal function<br \/>\n<h3> IMPORTANT DRUG INTERACTIONS<\/h3>\n<p>Potentially hazardous interactions with other drugs<\/li>\n<li>Analgesics: increased risk of   nephrotoxicity with NSAIDs; antagonism of diuretic effect<\/li>\n<li>Anti-arrhythmics: hypokalaemia leads   to increased cardiac toxicity; effects of lidocaine and mexiletine antagonised<\/li>\n<li>Antibacterials: avoid administration with   lymecycline<\/li>\n<li>Antidepressants: increased risk of   hypokalaemia with reboxetine; enhanced hypotensive effect with MAOIs; increased risk of postural hypotension with tricyclics<\/li>\n<li>Anti-epileptics: increased risk of   hyponatraemia with carbamazepine<\/li>\n<li>  Antifungals: increased risk of   hypokalaemia with amphotericin Antihypertensives: enhanced hypotensive   effect; increased risk of first dose hypotension with post-synaptic alpha- blockers like prazosin; hypokalaemia increases risk of ventricular arrhythmias with sotalol<\/li>\n<li>Antipsychotics: hypokalaemia increases   risk of ventricular arrhythmias with amisulpride or sertindole; enhanced hypotensive effect with phenothiazines; hypokalaemia increases risk of ventricular arrhythmias with pimozide \u2013 avoid concomitant use<\/li>\n<li>Atomoxetine: hypokalaemia increases risk   of ventricular arrhythmias Cardiac glycosides: increased toxicity if   hypokalaemia occurs<\/li>\n<li>Ciclosporin: increased risk of   nephrotoxicity and possibly hypomagnesaemia Lithium excretion reduced (increased   toxicity)<br \/>\n<h3> ADMINISTRATION<\/h3>\n<h4> Reconstition<\/h4>\n<p>\u2013<\/p>\n<h4>  Route<\/h4>\n<p>Oral<\/p>\n<h4>  Rate of Administration<\/h4>\n<p>\u2013<\/p>\n<h4>Comments<\/h4>\n<p>\u2013<\/p>\n<h4>  OTHER INFORMATION<\/h4>\n<p>Monitor for hypokalaemia   Diuresis starts within 1\u20132 hours, peaks at   4\u20136 hours and lasts for almost 24 hours Manufacturer advises to avoid in severe   renal impairment due to reduced clearance<\/li>\n","protected":false},"excerpt":{"rendered":"<p>CLINICAL USE Thiazide diuretic: Hypertension Oedema DOSE IN NORMAL RENAL<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-2286","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/2286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=2286"}],"version-history":[{"count":1,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/2286\/revisions"}],"predecessor-version":[{"id":2308,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/2286\/revisions\/2308"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=2286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=2286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=2286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}